This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Top European Pathologist Joins RUSVM To Lead New Postgraduate Degree Programs

Ross University School of Veterinary Medicine (RUSVM) announced the appointment of Dr. Sean Callanan as director of postgraduate studies who will oversee RUSVM’s first postgraduate degree programs focused in research. RUSVM has been awarding veterinary medicine degrees since 1982 and will now expand its programs to include master’s and doctoral degrees.

The new degree programs provide opportunities for students with science or veterinary educational backgrounds to specialize in global issues related to human-animal interactions, such as diseases that transfer between species. Courses of study include wildlife conservation and tropical animal health. Students will benefit from the school’s location in St. Kitts, an island in the West Indies, where they will be able to work with animals that live in a wide range of ecosystems.

“My intention is to ensure strong mentorship, equip students with the ability to problem solve and encourage their curiosity to pursue complex research questions,” Dr. Callanan said. “I’m very excited to be given the opportunity to lead this new initiative in a school that is currently establishing itself as the leading animal-health research and training institute in the region.”

Dr. Callanan completed his degree in veterinary medicine at the University College Dublin in his native Ireland and received his Ph.D. degree and pathology training from the University of Glasgow in Scotland. He has a strong interest in neuroscience and is well-known for his discovery and characterization of a new neuroinflammatory disorder in Irish greyhounds.

Much of Dr. Callanan’s research has focused on feline immunodeficiency virus (FIV), which is recognized as a model for HIV infection in humans. His early work revealed that within weeks of infection, FIV can cross the blood-brain barrier; once the virus infects the brain it can avoid drug therapies and multiply unchecked. His pioneering work also includes collaborations with Trinity College Dublin on the evaluation of novel therapies for human neurodegenerative disorders.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,081.11 +0.97 0.01%
S&P 500 2,116.36 -1.33 -0.06%
NASDAQ 5,078.1770 -13.9080 -0.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs